Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2021-06-25 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (2008 characters) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, explicitly stating it is provided by 'RNS, the news service of the London Stock Exchange'. It also includes a note about the potential decommissioning of 'Price Monitoring Extension announcements' and solicits feedback. This structure—a brief, specific operational update distributed via the RNS system—fits best under the general Regulatory Filings category, as it is not a core financial report (like 10-K, IR, ER) nor a specific corporate action like a dividend or management change. Given the explicit mention of RNS and the nature of the update, RNS is the most appropriate classification.
2021-06-25 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. It details a 'Price Monitoring Extension' which is a specific operational announcement related to trading on the exchange. Since this is a general regulatory announcement that doesn't fit into the specific categories like 10-K, ER, or DIV, and it is clearly distributed via the RNS system, the most appropriate classification is the general regulatory filing category.
2021-06-25 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It is a short, specific regulatory announcement disseminated via the RNS system, which is approved by the FCA to act as a Primary Information Provider. This type of specific, non-standard regulatory update that doesn't fit into the core financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS, as per the definitions and the 'MENU VS MEAL' rule (it is an announcement, not a comprehensive report).
2021-06-22 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. It details an administrative update regarding 'Price Monitoring Extension' announcements and solicits feedback on them. This is a general regulatory announcement distributed via the RNS system, which fits the definition of a miscellaneous regulatory filing that doesn't fit a more specific category like ER, 10-K, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short (2024 chars), but it is not announcing the publication of a major report, but rather an administrative notice about the RNS service itself.
2021-06-22 English
Block listing Interim Review
Regulatory Filings Classification · 1% confidence The document is identified by the 'RNS Number' header and contains structured data related to a 'Block Listing Six Monthly Return' for 'genedrive plc'. It details the status of unallocated securities under a share option scheme over a specific period (29 November 2020 to 28 May 2021). This type of routine regulatory update, distributed via RNS (the news service of the London Stock Exchange), does not fit neatly into the specific financial report categories (like 10-K, IR, ER) or corporate action categories (like DIV, CAP). Since it is a standard regulatory announcement distributed through the RNS system and doesn't match any other specific category, the most appropriate classification is the general regulatory filing fallback.
2021-05-28 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1926 characters) and contains the header 'RNS Number : 2638A'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This type of brief, immediate regulatory announcement that doesn't fit a specific financial reporting category (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2021-05-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.